Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
fda
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
abbvie
acorda therapeutics
akcea therapeutics
alder biopharmaceuticals
alnylam pharmaceuticals
amgen
ampyra
andrew fire
apokyn
apomorphine
biotech
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
craig mello
dalfampridine
david rind
detroit blog main
detroit top stories
duopa
eli lilly
episodic migraine
eptinezumab
erenumab
food and drug administration
What
drug
fda
3
×
gets
3
×
approved
new
nod
acorda
afternoon
alnylam
alnylam’s
amgen
approval
candidates
class
cope
developed
disease
episodes
friday
head
help
history
landmark
late
looms
making
meant
medications
medicine
medicines
migraine
ok
onpattro
pain
parkinson’s
patients
patisiran
pharmaceuticals
preventive
rival
Language
Current search:
gets
×
fda
×
" boston top stories "
×
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines